Cerebral board members agree to replace CEO in federal probe into prescribing practices

Directors who control Cerebral Inc.’s board of directors have agreed to a CEO replacement plan Kyle Robertsonsparking uproar within the mental health startup as it faces scrutiny over its controlled substance prescribing practices, people familiar with the matter said on Tuesday.

Investors and an independent director who together control four of the seven board seats have agreed that Mr Robertson should be replaced by the company’s chairman and chief medical officer, David Mou, some people said. Mr Robertson, who is also a co-founder of Cerebral and controls the other three headquarters, did not attend the meeting but subsequently lost access to the company’s Slack messaging system without notice , said another person. Mr Robertson had not agreed to quit his role as CEO on Tuesday night, the people said.


Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button